Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Color Diagnostics, |
RCV000583476 | SCV000691313 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-21 | criteria provided, single submitter | clinical testing | |
| Ce |
RCV002292569 | SCV002585641 | likely benign | not provided | 2025-05-01 | criteria provided, single submitter | clinical testing | RAD51D: BP4, BS1 |
| ARUP Laboratories, |
RCV005231132 | SCV005877527 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-05-22 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003945368 | SCV004764385 | likely benign | RAD51D-related disorder | 2019-04-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |